D-Index & Metrics Best Publications

Michael L. Shelanski

Columbia University
United States

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Biology and Biochemistry D-index 63 Citations 22,399 112 World Ranking 6487 National Ranking 3031

Research.com Recognitions

Awards & Achievements

1999 - Member of the National Academy of Medicine (NAM)

1973 - Fellow of John Simon Guggenheim Memorial Foundation

Overview

What is he best known for?

The fields of study Michael L. Shelanski is best known for:

Gene
Cyclic adenosine monophosphate
Enzyme

His Cell biology study frequently draws parallels with other fields, such as Protein kinase A. Michael L. Shelanski integrates Protein kinase A and Cyclic adenosine monophosphate in his studies. Michael L. Shelanski performs multidisciplinary study in Cyclic adenosine monophosphate and Forskolin in his work. His Receptor research extends to the thematically linked field of Forskolin. His work on Receptor is being expanded to include thematically relevant topics such as Long-term potentiation. In his articles, he combines various disciplines, including Long-term potentiation and CREB. Michael L. Shelanski integrates CREB with Gene in his research. Michael L. Shelanski incorporates Gene and Function (biology) in his studies. His research on Function (biology) frequently connects to adjacent areas such as Cell biology.

His most cited work include:

The National Alzheimer's Coordinating Center (NACC) Database: The Uniform Data Set (481 citations)
Amyloid β-peptide inhibition of the PKA/CREB pathway and long-term potentiation: Reversibility by drugs that enhance cAMP signaling (470 citations)
Ubiquitin Hydrolase Uch-L1 Rescues β-Amyloid-Induced Decreases in Synaptic Function and Contextual Memory (368 citations)

What are the main themes of his work throughout his whole career to date

His Biochemistry study frequently draws connections between adjacent fields such as Peptide. Much of his study explores Peptide relationship to Biochemistry. Cell biology and SPINE (molecular biology) are frequently intertwined in his study. As part of his studies on SPINE (molecular biology), Michael L. Shelanski frequently links adjacent subjects like Cell biology. In his research, he performs multidisciplinary study on Neuroscience and Pharmacology. Pharmacology and Neuroscience are two areas of study in which he engages in interdisciplinary research. Many of his studies on Disease involve topics that are commonly interrelated, such as Amyloid precursor protein. In his research, Michael L. Shelanski performs multidisciplinary study on Amyloid precursor protein and Alzheimer's disease. In his research, Michael L. Shelanski undertakes multidisciplinary study on Alzheimer's disease and Presenilin.

Michael L. Shelanski most often published in these fields:

Biochemistry (73.33%)
Cell biology (66.67%)
Neuroscience (66.67%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Microtubule Assembly in the Absence of Added Nucleotides

Michael L. Shelanski;Felicia Gaskin;Charles R. Cantor.
Proceedings of the National Academy of Sciences of the United States of America (1973)

2890 Citations

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

Adam C. Naj;Gyungah Jun;Gary W. Beecham;Li-San Wang.
Nature Genetics (2011)

1885 Citations

Primary care outcomes in patients treated by nurse practitioners or physicians: a randomized trial.

Mary O. Mundinger;Robert L. Kane;Elizabeth R. Lenz;Annette M. Totten.
JAMA (2000)

1313 Citations

Primary age-related tauopathy (PART): a common pathology associated with human aging

John F. Crary;John Q. Trojanowski;Julie A. Schneider;Jose F. Abisambra.
Acta Neuropathologica (2014)

1045 Citations

Synergistic Effects of Traumatic Head Injury and Apolipoprotein-epsilon4 in Patients With Alzheimer's Disease

R. Mayeux;R. Ottman;G. Maestre;C. Ngai.
Neurology (1995)

778 Citations

Astroglia in CNS injury

Mary E. Hatten;Ronald K. H. Liem;Michael L. Shelanski;Corol A. Mason.
Glia (1991)

734 Citations

Amyloid β-peptide inhibition of the PKA/CREB pathway and long-term potentiation: Reversibility by drugs that enhance cAMP signaling

Ottavio V. Vitolo;Antonino Sant'Angelo;Vincenzo Costanzo;Fortunato Battaglia.
Proceedings of the National Academy of Sciences of the United States of America (2002)

594 Citations

Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment

Bing Gong;Ottavio V. Vitolo;Fabrizio Trinchese;Shumin Liu.
Journal of Clinical Investigation (2004)

533 Citations

The National Alzheimer's Coordinating Center (NACC) database: the Uniform Data Set.

Duane L. Beekly;Erin M. Ramos;William W. Lee;Woodrow D. Deitrich.
Alzheimer Disease & Associated Disorders (2007)

471 Citations

Sequence of a cDNA clone encoding mouse glial fibrillary acidic protein: structural conservation of intermediate filaments

Sally A. Lewis;Joanna M. Balcarek;Veronica Krek;Michael Shelanski.
Proceedings of the National Academy of Sciences of the United States of America (1984)

459 Citations

If you think any of the details on this page are incorrect, let us know.